CVS Health Corporation (CVS)
CVS to pay $315 million settlement to resolve DOJ opioid lawsuit
CVS Pharmacy Inc. and various subsidiaries have agreed to pay $315 million to resolve a Justice Department case alleging it unlawfully dispensed medically unnecessary prescriptions of highly addictive opioids, officials said Tuesday.
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
CVS Stock Dips After Drop in Medicare Advantage Plan Ratings
Aetna, the insurance arm of CVS Health, saw its four-star or higher plans lose ground in the latest federal ratings.
CVS Health Trades at a Discount to Industry: How to Play the Stock?
CVS trades below industry peers as Aetna margins recover, pharmacy trends improve and Health Services gains momentum, but 340B headwinds persist.
Here's Why CVS Health (CVS) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS Health (CVS) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, CVS Health (CVS) stood at $87.95, denoting a +1.76% move from the preceding trading day.
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why CVS Is ‘Insanely Cheap,' ON Semi a Laggard Catching Up, and Grail Too Expensive to Chase
Jim Cramer sees three stocks with very different amounts of bad news or good news already baked into their prices, and figuring out which side each sits on changes everything about whether to buy.
CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?
CVS Health raises its Health Care Benefits outlook as stronger core trends, led by Medicare, support margin recovery despite medical cost pressures.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
CVS Health Stock Still Looks Good Even If Health Cost Woes Materialize
CVS Health Corporation stock remains fairly attractive as a growing industry leader, currently rated a soft Buy due to improved profitability and relative valuation. Recent results show revenue up 6.7% year-over-year to $206.5B and net income more than doubling, driven by segment-level operational improvements. CVS's Health Care Benefits segment reversed prior profitability declines, aided by strategic exits and a lower medical benefit ratio (MBR) now at 86%.
